Pfizer India ropes in Pradip Shah as Chairman
New Delhi: Pfizer India has recently announced the appointment of Pradip Shah, Independent Director as the Chairman of the Board of Directors of the Company with immediate effect.
Mr. Pradip Shah holds an MBA from the Harvard Business School. He is also a Chartered Accountant and a Cost Accountant and ranked first in India in the Chartered Accountancy Examination.
Mr. Pradip Shah is the ex-Managing Director of CRISIL. Prior to founding CRISIL, Mr. Pradip Shah assisted in founding the Housing Development Finance Corporation (HDFC) in 1977. Mr. Shah has also served as a consultant to USAID, the World Bank and the Asian Development Bank. Mr. Shah is a Director on the Board of several reputed companies. He is also a member of various prestigious committees/commissions. Mr. Pradip Shah is presently the Chairman of Indasia Fund Advisors Pvt. Ltd.
Mr. Pradip P. Shah was appointed to the Board on December 7, 1999.
Read also: William Pao appointed as Pfizer Executive Vice President
Founded in 1950, Pfizer India is the fourth largest multinational pharmaceutical company in India with annual sales of over Rs. 2,000 crores. The Company has a portfolio of over 150 products across 15 therapeutic areas.
Its top brands include Prevenar 13, Lyrica, Corex – DX, Dolonex, Enbrel, Becosules, Gelusil and Folvite among others. In addition to its commercial operations, Pfizer Limited also operates a state-of-the-art, award-winning manufacturing facility in Goa that produces more than a billion tablets annually.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd